New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 10, 2014
14:22 EDTNEOCortina Asset reports 5.05% passive stake in NeoGenomics
News For NEO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 25, 2015
08:40 EDTNEONeoGenomics reimbursement rates could rebound, says Roth Capital
Roth Capital expects reimbursement rates for NeoGenomics' tests to rebound in 2H15, since the firm believes, based on data, that most labs are probably performing the tests below costs. The firm keeps a $7 price target and Buy rating on NeoGenomics.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use